Bravo-San Pedro José Manuel, Sica Valentina, Kroemer Guido
INSERM U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.
Team "Metabolism, Cancer & Immunity" labellisée par la Ligue contre le Cancer, Paris, France.
Mol Cell Oncol. 2019 Oct 15;6(6):e1667193. doi: 10.1080/23723556.2019.1667193. eCollection 2019.
Paradoxically, most if not all previously known appetite-stimulatory hormones are downregulated in human obesity, reflecting failing homeostatic circuitries. Recently, we discovered that acyl-coenzyme-A binding protein/diazepam-binding inhibitor (ACBP/DBI) acts as a lipogenic and appetite stimulator, when systemically injected into mice. ACBP/DBI plasma levels are also elevated in obese subjects, supporting the notion that it may represent the elusive "hunger protein" that explains overeating in human obesity.
矛盾的是,大多数(如果不是全部的话)先前已知的食欲刺激激素在人类肥胖中表达下调,这反映了体内平衡调节机制的失效。最近,我们发现,当将酰基辅酶A结合蛋白/地西泮结合抑制剂(ACBP/DBI)全身注射到小鼠体内时,它可作为一种脂肪生成和食欲刺激因子。肥胖受试者的ACBP/DBI血浆水平也会升高,这支持了一种观点,即它可能就是难以捉摸的“饥饿蛋白”,可以解释人类肥胖中的暴饮暴食现象。